Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ball

Showing results (231-240 of 265) with videos related to

Pageof 27
Sort By:
AJNR. American Journal of Neuroradiology|September 1, 1991
Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findingsS M Roman-Goldstein, P A Barnett, C I McCormick, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1993
Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophyS J Kish, Y Robitaille, M el-Awar, et al.
Methods of Information in Medicine|January 24, 2008
Failure to provide clinicians useful IT systems: opportunities to leapfrog current technologiesM J Ball, J S Silva, S Bierstock, et al.
The New Zealand Medical Journal|September 11, 1991
Blood lipid levels in New ZealandJ I Mann, A Duncan, M J Ball, et al.
The British Journal of Surgery|August 1, 1987
Use of a lipid containing medium chain triglycerides in patients receiving TPN: a randomized prospective trialP J Clarke, M J Ball, L J Hands, et al.
Annals of Neurology|January 1, 1991
Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophyS J Kish, F Du, D A Parks, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1993
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer diseaseA E Roher, J D Lowenson, S Clarke, et al.
The Journal of Biological Chemistry|April 15, 1994
Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer diseaseE Gowing, A E Roher, A S Woods, et al.
The Journal of Nutrition, Health & Aging|April 30, 2015
Omega-3 dietary Fatty Acid status of healthy older adults in Tasmania, Australia: an observational studyJ K Pittaway, L T Chuang, K D K Ahuja, et al.
Brain Research|December 26, 1994
Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy studyP F Kwo-On-Yuen, R D Newmark, T F Budinger, et al.
Pageof 27

Showing results (231-240 of 265) with videos related to

Sort By:
Pageof 27
AJNR. American Journal of Neuroradiology|September 1, 1991
Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findingsS M Roman-Goldstein, P A Barnett, C I McCormick, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1993
Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophyS J Kish, Y Robitaille, M el-Awar, et al.
Methods of Information in Medicine|January 24, 2008
Failure to provide clinicians useful IT systems: opportunities to leapfrog current technologiesM J Ball, J S Silva, S Bierstock, et al.
The New Zealand Medical Journal|September 11, 1991
Blood lipid levels in New ZealandJ I Mann, A Duncan, M J Ball, et al.
The British Journal of Surgery|August 1, 1987
Use of a lipid containing medium chain triglycerides in patients receiving TPN: a randomized prospective trialP J Clarke, M J Ball, L J Hands, et al.
Annals of Neurology|January 1, 1991
Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophyS J Kish, F Du, D A Parks, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1993
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer diseaseA E Roher, J D Lowenson, S Clarke, et al.
The Journal of Biological Chemistry|April 15, 1994
Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer diseaseE Gowing, A E Roher, A S Woods, et al.
The Journal of Nutrition, Health & Aging|April 30, 2015
Omega-3 dietary Fatty Acid status of healthy older adults in Tasmania, Australia: an observational studyJ K Pittaway, L T Chuang, K D K Ahuja, et al.
Brain Research|December 26, 1994
Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy studyP F Kwo-On-Yuen, R D Newmark, T F Budinger, et al.
Pageof 27